February 8, 2025 Week in Review: Trade Wars, Earnings, and Labor Data
February 4, 2025 AI Ventures Soar as Trade Tensions Heat Up – Key Weekly Highlights
January 27, 2025 China’s DeepSeek Challenges U.S. AI Giants, Shakes Tech Markets
Amazon’s Growth Engine: Cloud Dominance and Strategic Investments
3M Company: Is It Time to Lock in Gains Amid Uncertain Outlook?
Apple: Steady Growth and Value in a Challenging Market
Tesla: Navigating Growth Amid Market Pressures
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
January 1, 2025 Advanced Charting Tools For Traders
December 21, 2024 Why Is Trading Important?
Trevi Therapeutics (TRVI) Stock Forecast for 2025, 2026, 2027. Sell or Buy?
Updated: February 10, 2025 (10:54)
Sector: HealthcareThe share price of Trevi Therapeutics, Inc. (TRVI) now
Are you interested in Trevi Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Trevi Therapeutics stock price in 2025, 2026, 2027. How much will one Trevi Therapeutics share be worth in 2025 - 2027?
When should I take profit in Trevi Therapeutics stock? When should I record a loss on Trevi Therapeutics stock? What are analysts' forecasts for Trevi Therapeutics stock? What is the future of Trevi Therapeutics stock? We forecast Trevi Therapeutics stock performance using neural networks based on historical data on Trevi Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Trevi Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Trevi Therapeutics shares. This happens once a day.
Historical and forecast chart of Trevi Therapeutics stock
The chart below shows the historical price of Trevi Therapeutics stock and a prediction chart for the next month.
For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast,
and Weighted Average Best Forecast. Detailed values for the Trevi Therapeutics stock price can be found in the table below.
Long-term forecasts by years.
Trevi Therapeutics Inc. is a clinical biopharmaceutical company focused on the development and commercialization of Nalbuphine ER for the treatment of neurologically mediated conditions. The company is developing nalbuphine ER for the treatment of chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis (IPF) and levodopa-induced dyskinesia (LD), in patients with Parkinson’s disease. The company is conducting phase 2b/3 clinical trials for nalbuphine ER. The company has also initiated a phase 1b clinical trial in patients with chronic liver disease to evaluate the safety, pharmacokinetics, and antipruritic effect of nalbuphine ER in this population. The Company’s nalbuphine development programs for ER include the Chronic Pruritus Program, the Nodular Pruritus Program, the Chronic Liver Disease Pruritus Program, and the Uremic Pruritus Program.
Trevi Therapeutics daily forecast for a month
Date | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Feb 12 | 4.30 | 4.16 | 4.72 | 13.52 |
Feb 13 | 4.23 | 3.83 | 4.64 | 21.24 |
Feb 14 | 3.97 | 3.67 | 4.13 | 12.49 |
Feb 15 | 3.78 | 3.39 | 3.93 | 15.90 |
Feb 16 | 3.98 | 3.59 | 4.40 | 22.81 |
Feb 17 | 4.49 | 4.27 | 5.00 | 17.04 |
Feb 18 | 4.66 | 4.52 | 4.92 | 8.97 |
Feb 19 | 4.69 | 4.39 | 5.06 | 15.05 |
Feb 20 | 4.47 | 4.12 | 4.66 | 13.20 |
Feb 21 | 3.92 | 3.55 | 4.18 | 17.89 |
Feb 22 | 3.46 | 3.26 | 3.73 | 14.47 |
Feb 23 | 3.94 | 3.48 | 4.34 | 24.84 |
Feb 24 | 4.24 | 4.03 | 4.39 | 8.84 |
Feb 25 | 4.00 | 3.68 | 4.23 | 14.83 |
Feb 26 | 4.30 | 3.98 | 4.63 | 16.57 |
Feb 27 | 4.72 | 4.39 | 4.90 | 11.78 |
Feb 28 | 5.30 | 4.93 | 5.89 | 19.50 |
Mar 01 | 5.43 | 5.21 | 6.07 | 16.41 |
Mar 02 | 4.90 | 4.49 | 5.35 | 19.00 |
Mar 03 | 4.19 | 3.87 | 4.44 | 14.78 |
Mar 04 | 4.17 | 3.97 | 4.49 | 13.24 |
Mar 05 | 4.33 | 4.08 | 4.47 | 9.56 |
Mar 06 | 4.78 | 4.55 | 5.06 | 11.19 |
Mar 07 | 4.85 | 4.31 | 5.30 | 22.99 |
Mar 08 | 5.43 | 5.14 | 5.71 | 10.92 |
Mar 09 | 5.19 | 5.00 | 5.78 | 15.72 |
Mar 10 | 5.15 | 4.55 | 5.66 | 24.46 |
Mar 11 | 4.62 | 4.12 | 4.93 | 19.51 |
Mar 12 | 4.63 | 4.09 | 4.93 | 20.56 |
Mar 13 | 4.16 | 3.69 | 4.42 | 19.77 |
Trevi Therapeutics Daily Price Targets
Trevi Therapeutics Stock Forecast 02-12-2025.
Forecast target price for 02-12-2025: $4.30.
Positive dynamics for Trevi Therapeutics shares will prevail with possible volatility of 11.907%.
Pessimistic target level: 4.16
Optimistic target level: 4.72
Trevi Therapeutics Stock Forecast 02-13-2025.
Forecast target price for 02-13-2025: $4.23.
Negative dynamics for Trevi Therapeutics shares will prevail with possible volatility of 17.518%.
Pessimistic target level: 3.83
Optimistic target level: 4.64
Trevi Therapeutics Stock Forecast 02-14-2025.
Forecast target price for 02-14-2025: $3.97.
Negative dynamics for Trevi Therapeutics shares will prevail with possible volatility of 11.100%.
Pessimistic target level: 3.67
Optimistic target level: 4.13
Trevi Therapeutics Stock Forecast 02-15-2025.
Forecast target price for 02-15-2025: $3.78.
Negative dynamics for Trevi Therapeutics shares will prevail with possible volatility of 13.715%.
Pessimistic target level: 3.39
Optimistic target level: 3.93
Trevi Therapeutics Stock Forecast 02-16-2025.
Forecast target price for 02-16-2025: $3.98.
Positive dynamics for Trevi Therapeutics shares will prevail with possible volatility of 18.572%.
Pessimistic target level: 3.59
Optimistic target level: 4.40
Trevi Therapeutics Stock Forecast 02-17-2025.
Forecast target price for 02-17-2025: $4.49.
Positive dynamics for Trevi Therapeutics shares will prevail with possible volatility of 14.562%.
Pessimistic target level: 4.27
Optimistic target level: 5.00
TRVI (TRVI) Monthly Stock Prediction for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Mar. | 5.10 | 4.51 | 5.55 | 18.77 |
Apr. | 4.49 | 3.99 | 5.02 | 20.41 |
May. | 4.15 | 3.54 | 4.78 | 25.83 |
Jun. | 4.12 | 3.47 | 5.09 | 31.77 |
Jul. | 4.19 | 3.75 | 5.05 | 25.66 |
Aug. | 4.45 | 4.11 | 5.30 | 22.46 |
Sep. | 5.74 | 4.89 | 6.87 | 28.80 |
Oct. | 6.19 | 5.31 | 7.00 | 24.12 |
Nov. | 6.93 | 5.62 | 7.47 | 24.77 |
Dec. | 5.74 | 4.66 | 6.42 | 27.39 |
Trevi Therapeutics forecast for this year
Trevi Therapeutics Stock Prediction for Mar 2025
An uptrend is forecast for this month with an optimal target price of $5.10348. Pessimistic: $4.51. Optimistic: $5.55
Trevi Therapeutics Stock Prediction for Apr 2025
An downtrend is forecast for this month with an optimal target price of $4.49106. Pessimistic: $3.99. Optimistic: $5.02
Trevi Therapeutics Stock Prediction for May 2025
An downtrend is forecast for this month with an optimal target price of $4.15423. Pessimistic: $3.54. Optimistic: $4.78
Trevi Therapeutics Stock Prediction for Jun 2025
An downtrend is forecast for this month with an optimal target price of $4.11684. Pessimistic: $3.47. Optimistic: $5.09
Trevi Therapeutics Stock Prediction for Jul 2025
An uptrend is forecast for this month with an optimal target price of $4.19095. Pessimistic: $3.75. Optimistic: $5.05
Trevi Therapeutics Stock Prediction for Aug 2025
An uptrend is forecast for this month with an optimal target price of $4.45498. Pessimistic: $4.11. Optimistic: $5.30
Trevi Therapeutics Stock Prediction for Sep 2025
An uptrend is forecast for this month with an optimal target price of $5.73801. Pessimistic: $4.89. Optimistic: $6.87
Trevi Therapeutics Stock Prediction for Oct 2025
An uptrend is forecast for this month with an optimal target price of $6.18558. Pessimistic: $5.31. Optimistic: $7.00
Trevi Therapeutics Stock Prediction for Nov 2025
An uptrend is forecast for this month with an optimal target price of $6.92785. Pessimistic: $5.62. Optimistic: $7.47
Trevi Therapeutics Stock Prediction for Dec 2025
An downtrend is forecast for this month with an optimal target price of $5.74318. Pessimistic: $4.66. Optimistic: $6.42
Trevi Therapeutics (TRVI) Monthly Stock Prediction for 2026
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 5.19 | 4.88 | 5.80 | 15.85 |
Feb | 3.99 | 3.09 | 4.85 | 36.27 |
Mar | 3.53 | 2.87 | 3.95 | 27.32 |
Apr | 4.39 | 3.43 | 5.09 | 32.61 |
May | 5.33 | 4.72 | 5.81 | 18.72 |
Jun | 5.42 | 5.00 | 6.50 | 23.04 |
Jul | 6.17 | 4.77 | 6.89 | 30.89 |
Aug | 6.25 | 4.84 | 7.41 | 34.65 |
Sep | 6.73 | 5.54 | 7.72 | 28.25 |
Oct | 7.46 | 5.67 | 8.92 | 36.40 |
Nov | 8.45 | 7.28 | 10.25 | 28.94 |
Dec | 8.42 | 7.89 | 9.73 | 18.94 |
Trevi Therapeutics (TRVI) Monthly Stock Prediction for 2027
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 9.18 | 8.41 | 10.64 | 20.97 |
Feb | 9.48 | 7.97 | 10.90 | 26.87 |
Mar | 11.62 | 10.43 | 14.16 | 26.33 |
Apr | 11.02 | 8.84 | 13.40 | 34.05 |
May | 10.66 | 8.71 | 12.45 | 30.05 |
Jun | 11.68 | 9.82 | 13.89 | 29.27 |
Jul | 11.16 | 10.29 | 13.10 | 21.46 |
Aug | 12.33 | 10.81 | 13.18 | 17.96 |
Sep | 13.88 | 10.84 | 14.92 | 27.35 |
Oct | 18.05 | 14.85 | 22.00 | 32.49 |
Nov | 15.39 | 14.47 | 17.61 | 17.83 |
Dec | 17.42 | 16.12 | 20.09 | 19.77 |
Trevi Therapeutics information and performance
195 CHURCH STREET, 14TH FLOOR, NEW HAVEN, CT, US
Market capitalization of the Trevi Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of TRVI shares in the company outstanding by the market price of one share.
EBITDA of Trevi Therapeutics is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
FAQ (Frequently Asked Questions about Trevi Therapeutics Stock)
Should I Buy Trevi Therapeutics Shares in 2025 year?
Does Trevi Therapeutics pay dividends?
Which economic sector do Trevi Therapeutics's shares belong to?
Which other securities belong to the same sector as Trevi Therapeutics's shares?
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.